Insider Selling: Itron (NASDAQ:ITRI) SVP Sells $82,940.76 in Stock

Itron, Inc. (NASDAQ:ITRI) SVP Justin Patrick sold 828 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $100.17, for a total value of $82,940.76. Following the transaction, the senior vice president owned 33,516 shares of the company’s stock, valued at $3,357,297.72. This represents a 2.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Itron Stock Down 0.7%

Shares of NASDAQ ITRI opened at $97.15 on Thursday. The firm has a 50-day simple moving average of $97.82 and a two-hundred day simple moving average of $109.44. The company has a market cap of $4.37 billion, a P/E ratio of 14.92, a PEG ratio of 0.85 and a beta of 1.48. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56. Itron, Inc. has a 1 year low of $88.57 and a 1 year high of $142.00.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.19 by $0.27. Itron had a net margin of 12.72% and a return on equity of 20.04%. The firm had revenue of $571.66 million during the quarter, compared to the consensus estimate of $561.31 million. During the same quarter in the previous year, the firm posted $1.35 earnings per share. The company’s revenue was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Research analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current year.

Itron News Summary

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Itron’s Q4 results and guidance surprised to the upside — the company reported an EPS beat and set Q1 and FY2026 EPS guidance that supports continued profitability, which is a constructive fundamental datapoint for valuation and near‑term earnings expectations. 5 Insightful Analyst Questions From Itron’s Q4 Earnings Call
• Neutral Sentiment: Itron priced an upsized $700M 0.00% convertible senior notes offering due 2032; proceeds will fund a $100M concurrent repurchase, capped‑call hedges, repayment of existing 2026 convertible notes and general corporate purposes. The structure (conversion price ≈ $123.77, capped call cap ≈ $190.42) reduces immediate cash interest but introduces conversion/dilution mechanics and near‑term hedging activity that may create volatility. Itron Prices Upsized $700.0 Million Convertible Senior Notes Offering
• Negative Sentiment: A concentrated cluster of insider stock sales by multiple senior executives (including the CFO and several SVPs) occurred around Feb. 19–20 at prices near $99–$100 — the volume and timing (many filings disclosed in the same window) can be read negatively by the market as increased supply or reduced insider conviction. Wave of Insider Moves as Itron’s Top Brass Cash In on Company Stock
• Negative Sentiment: Institutional rebalancing reported in recent datasets shows several large asset managers materially reducing ITRI positions in the latest quarter — such outflows from big holders can amplify downward pressure if sustained. Quiver Quant Summary (includes institutional and insider activity)

Hedge Funds Weigh In On Itron

A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Itron by 2.3% during the third quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company’s stock valued at $731,809,000 after buying an additional 132,329 shares during the last quarter. Impax Asset Management Group plc boosted its position in shares of Itron by 127.3% in the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock worth $197,153,000 after buying an additional 890,040 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Itron by 18.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock valued at $118,034,000 after buying an additional 194,768 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Itron by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock worth $106,340,000 after purchasing an additional 6,598 shares during the last quarter. Finally, Handelsbanken Fonder AB raised its holdings in shares of Itron by 6.0% during the 3rd quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company’s stock valued at $124,545,000 after purchasing an additional 56,318 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Wall Street Analysts Forecast Growth

ITRI has been the subject of several research analyst reports. Johnson Rice upgraded Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective for the company in a research note on Monday, January 5th. Argus reaffirmed a “hold” rating on shares of Itron in a research note on Tuesday, November 4th. Zacks Research downgraded Itron from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 28th. Wall Street Zen downgraded shares of Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Finally, Stephens raised shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price target for the company in a research note on Monday, November 3rd. Seven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $138.56.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.